9 news items
Citigroup Maintains Buy on Luminar Technologies, Lowers Price Target to $9
LAZR
9 May 24
Citigroup analyst Itay Michaeli maintains Luminar Technologies (NASDAQ:LAZR) with a Buy and lowers the price target from $11 to $9.
Stocks Falter As Fed Signals Need For Higher-For-Longer Rates; Uber Crashes, Energy Sector Loses Ground: What's Driving Wednesday's Market?
ABNB
ANET
APP
8 May 24
to the Fed’s 2% target, cautioning against premature rate cuts.
The S&P 500, as tracked by the SPDR S&P 500 ETF
BioNTech Reports Downbeat Earnings, Joins Medical Properties Trust And Other Big Stocks Moving Lower In Monday's Pre-Market Session
ADCT
BNTX
LAZR
6 May 24
Equal-Weight to Underweight and lowered the price target from $19 to $15.
Now Read
M&T Bank Reports Q1 Earnings, Joins Snap One, Encore Wire And Other Big Stocks Moving Higher On Monday
AA
ACDC
BRFS
15 Apr 24
to Overweight. Goldman Sachs analyst Thiago Bortoluci upgraded BRF from Sell to Neutral and raised the price target from $1.9 to $3.1
Will Luminar Technologies Need To Raise $1B In Capital? This Bearish Analyst Answers
LAZR
10 Apr 24
slashing the price target from $3.50 to $1.20.
The Luminar Technologies Thesis: The company’s volumes are likely
fkso9zb4psdk9u956225og5
LAZR
10 Apr 24
(NASDAQ:LAZR) from Neutral to Underperform and lowers the price target from $3.5 to $1.2.
lgu91wkj3e5qhctlm amcoxxtxq3aez5xe4pchzzvj
LAZR
NRGV
4 Apr 24
," "believe," "intend," "project," "forecast," "estimates," "targets," "projections," "should," "could," "would," "may," "might," "will" and other
ho0ms 2ge7de4t4h5bukjj4tos9vq34qdhzj49zvzjyrcq03yne
ATNM
AZN
BMY
27 Mar 24
) to initiate a clinical trial for Iomab-ACT, a revolutionary targeted radiotherapy conditioning agent. This pioneering study, aimed at enhancing
9q2uv40
LAZR
26 Mar 24
JP Morgan analyst Samik Chatterjee assumes Luminar Technologies (NASDAQ:LAZR) with a Overweight rating and lowers Price Target of $8.
- Prev
- 1
- Next